Discontinued — last reported Q4 '25
Intel Impairment and restructuring decreased by 90.7% to $175.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 96.9%, from $5.62B to $175.00M. Over 3 years (FY 2021 to FY 2024), Impairment and restructuring shows an upward trend with a 38.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Frequent or large charges may signal poor capital allocation or a need for significant operational turnaround.
This metric aggregates charges related to the impairment of assets and costs associated with restructuring initiatives,...
Comparable to 'restructuring charges' or 'special items' reported by most large-cap corporations.
is_msft_impairment_and_restructuring| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $346.00M | $42.00M | $29.00M | -$1.21B | $87.00M | $664.00M | $462.00M | $64.00M | $200.00M | $816.00M | -$1.14B | $348.00M | $943.00M | $5.62B | $57.00M | $156.00M | $1.89B | $175.00M |
| QoQ Change | — | -87.9% | -31.0% | <-999% | +107.2% | +663.2% | -30.4% | -86.1% | +212.5% | +308.0% | -240.0% | +130.5% | +171.0% | +496.2% | -99.0% | +173.7% | >999% | -90.7% |
| YoY Change | — | — | — | — | -74.9% | >999% | >999% | +105.3% | +129.9% | +22.9% | -347.2% | +443.8% | +371.5% | +589.0% | +105.0% | -55.2% | +100.4% | -96.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.